Short answer
Point-of-care tests answer in minutes at the bedside, enabling same-visit treatment and counseling at the price of lower sensitivity and narrower menus.
Central-lab tests answer in days with definitive accuracy across comprehensive panels.
Modern sexual-health care uses both deliberately: rapids for triage and access, labs for certainty. With confirmatory ladders bridging the two tiers.
Advertisement
Need a test? STDTest.online is education-only and does not provide testing. The banner above is a paid advertisement for an independent testing service. We may earn a commission if you use it, at no extra cost to you. Always confirm current prices, accreditation, and privacy terms on their website before ordering.
See Tests & Prices →Tier comparison
| Dimension | Point-of-care | Central lab |
|---|---|---|
| Turnaround | Minutes | Days |
| Sensitivity | Lower | Reference standard |
| Menu breadth | Narrow | Comprehensive |
| Same-visit action | Yes | No |
| Confirmation role | Triage | Definitive |
HIV-specific version: Rapid HIV vs Lab HIV Tests.
When each tier leads
- Symptomatic walk-ins: rapid triage guides immediate care; labs confirm and complete.
- Outreach and events: rapids reach people labs never see; linkage programs close the loop.
- Routine screening: labs directly. No reason to accept rapid trade-offs on a schedule.
- High-stakes exposures: lab pathways from the start, with rapids as interim information only.
Home-kit parallel: rapids at home follow identical logic with weaker linkage. How Accurate Are Home STI Test Kits?.
Future of rapid testing
Rapid-test frontiers advance steadily: molecular point-of-care platforms bringing NAAT-like sensitivity to bedside timelines, multiplex rapids covering broader panels per encounter, and connectivity features streaming results into records automatically.
Each advance narrows (never yet closes) the rapid-versus-lab gap, shifting more decisions toward same-visit resolution over coming years.
Adoption discipline must match technological enthusiasm: validate new rapids against lab references before trusting them, maintain confirmatory ladders regardless of rapid improvements, and deploy rapids where access gaps (not convenience preferences) justify trade-offs.
Technology improves the rapid tier continuously; clinical judgment about tier selection remains permanently human.
Watch the frontier with guidelines, not marketing, as the guide.
When to seek care
Now if results and symptoms disagree, if a screening result surprised you, or if timing was early. Confirmatory workups and scheduled retests resolve what single results cannot.
Bring exposure dates and prior results to every follow-up.